$261 Million is the total value of Foresite Capital Management III, LLC's 25 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 200.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALDR | Buy | Alder BioPharmaceuticals, Inc. | $33,888,000 | +0.1% | 1,629,222 | +0.1% | 13.01% | -11.6% |
| AIMT | Buy | Aimmune Therapeutics, Inc. | $19,818,000 | +7.2% | 912,001 | +0.9% | 7.61% | -5.3% |
| EPZM | Buy | Epizyme, Inc. | $11,695,000 | +59.7% | 681,922 | +12.7% | 4.49% | +41.1% |
| BLCM | New | Bellicum Pharmaceuticals, Inc. | $11,328,000 | – | 918,000 | +100.0% | 4.35% | – |
| DERM | New | Dermira, Inc. | $6,011,000 | – | 176,211 | +100.0% | 2.31% | – |
| MNTA | New | Momenta Pharmaceuticals, Inc. | $5,749,000 | – | 430,632 | +100.0% | 2.21% | – |
| LOXO | New | Loxo Oncology, Inc. | $4,208,000 | – | 100,000 | +100.0% | 1.62% | – |
| NTRA | New | Natera, Inc. | $2,534,000 | – | 285,731 | +100.0% | 0.97% | – |
| FGEN | New | Fibrogen, Inc. | $2,169,000 | – | 87,984 | +100.0% | 0.83% | – |
| JNCE | New | Jounce Therapeutics, Inc. | $2,014,000 | – | 91,600 | +100.0% | 0.77% | – |
| OREXQ | Buy | Orexigen Therapeutics, Inc. | $1,309,000 | +196.2% | 380,530 | +49.7% | 0.50% | +161.5% |
| IMMU | New | Immunomedics, Inc. | $1,118,000 | – | 172,871 | +100.0% | 0.43% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Epizyme, Inc. | 24 | Q3 2021 | 17.6% |
| Acceleron Pharma Inc. | 22 | Q3 2021 | 25.9% |
| CymaBay Therapeutics, Inc. | 20 | Q3 2022 | 17.6% |
| Aerie Pharmaceuticals, Inc. | 18 | Q1 2020 | 33.5% |
| Ascendis Pharma A/S | 17 | Q3 2022 | 47.8% |
| Alder BioPharmaceuticals, Inc. | 16 | Q3 2019 | 27.4% |
| Natera, Inc. | 16 | Q3 2022 | 21.5% |
| Aimmune Therapeutics, Inc. | 16 | Q3 2019 | 8.1% |
| Verona Pharma PLC. | 15 | Q3 2022 | 30.0% |
| WAVE Life Sciences Ltd. | 15 | Q2 2019 | 20.0% |
View Foresite Capital Management III, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
| 13F-HR | 2021-11-12 |
| 4 | 2021-11-03 |
| 13F-HR | 2021-08-16 |
| 13F-HR | 2021-05-17 |
| 13F-HR | 2021-02-16 |
| 3 | 2021-02-10 |
View Foresite Capital Management III, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.